Cargando…
Liquid biopsy approach to pancreatic cancer
Pancreatic cancer (PC) continues to pose a major clinical challenge. There has been little improvement in patient survival over the past few decades, and it is projected to become the second leading cause of cancer mortality by 2030. The dismal 5-year survival rate of less than 10% after the diagnos...
Autores principales: | Perales, Sonia, Torres, Carolina, Jimenez-Luna, Cristina, Prados, Jose, Martinez-Galan, Joaquina, Sanchez-Manas, Jose Manuel, Caba, Octavio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529923/ https://www.ncbi.nlm.nih.gov/pubmed/34721766 http://dx.doi.org/10.4251/wjgo.v13.i10.1263 |
Ejemplares similares
-
Proteomic biomarkers in body fluids associated with pancreatic cancer
por: Jimenez-Luna, Cristina, et al.
Publicado: (2018) -
Role of Exocrine and Endocrine Insufficiency in the Management of Patients with Chronic Pancreatitis
por: Diéguez-Castillo, Carmelo, et al.
Publicado: (2020) -
Serum biomarkers for the differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma
por: Caba, Octavio, et al.
Publicado: (2023) -
Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2020) -
Prognosis Relevance of Serum Cytokines in Pancreatic Cancer
por: Torres, Carolina, et al.
Publicado: (2015)